Acquisition - January 17, 2018
Biotage’s acquisition of Horizon Technology is closed
Biotage announces the closing of the acquisition of all outstanding shares in the privately held company Horizon Technology, based in New Hampshire, US, in accordance with contract and public announcement of December 6th, 2017. The purchase price adjusted for actual net cash at the closing date is approximately USD 17.9 million, corresponding to approx. SEK 143.4 million, based […]
Acquisition - January 10, 2018
Takeda intends to acquire TiGenix
Takeda Pharmaceutical has announced its intention to acquire TiGenix, a biopharma company developing novel stem cell therapies for serious medical conditions, and the total value of the deal is estimated to approximately 520 million euro. As a result Takeda has entered into an offer and support agreement with TiGenix which provides for a recommended potential […]
Acquisition - June 29, 2017
Trimb acquires OTC products
Trimb Healthcare has acquired a portfolio of European OTC products from Cilag GmbH International and Janssen Pharmaceutica NV. The products, which include Pevaryl, Fungoral, Gyno-Pevaryl and Epi-Pevaryl, are based on the anti-fungal substances econazole and ketoconazole and are used to treat common fungal infections of the skin. The acquired territory includes Sweden, Norway, Germany, Switzerland, […]
Acquisition - April 10, 2017
New international owner of Medfiles Ltd from Japan
On the 21st of March 2017, WDB Holdings Co., Ltd, a listed Japanese Contract Research Organisation, bought Medfiles Ltd (100 % of the shares). Medfiles Group has been operating in Finland for over 30 years and 20 years in the Baltic countries. In the CRO business, Medfiles sells services in product development, laboratory analytics and QP certification […]
Acquisition - March 15, 2017
The new Teva grows stronger – in Norway
In August last year Teva completed its acquisition of Actavis Generics and the new Teva in Norway will be among the 15 largest companies in the country. The new company will be named Teva and will be located at Teva’s facilities in Hagaløkkveien in Asker. Employees from Actavis moved in with the Teva team in […]
Acquisition - January 9, 2017
PolyPeptide completes acquisition of Lonza’s peptides business
The PolyPeptide Group has announced that the acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium has been completed. The Braine facility, with approximately 280 employees, was the center for peptide chemical development and manufacturing within Lonza. The acquisition will enhance PolyPeptide’s manufacturing capacity and capabilities and will enable seamless support for its […]
